2026 Claude G. Wasterlain: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	71	2438	2229	1151	1034	246	15722

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

2438

2229

1151

1034

246

15722

Overview

Claude G. Wasterlain is affiliated with the University of California, Los Angeles in the United States. Their research focuses primarily on the fields of Medicine and Neuroscience, with significant contributions to Psychiatry and Mental Health, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Pediatrics, Perinatology and Child Health, and Pharmacology.

The main topics addressed in their work include:

Epilepsy research and treatment
Neuroscience and Neuropharmacology Research
Memory and Neural Mechanisms
Pharmacological Effects and Toxicity Studies
Cholinesterase and Neurodegenerative Diseases
Anesthesia and Neurotoxicity Research
Neurological disorders and treatments

Wasterlain has published in several journals, with frequent publications in:

Epilepsia Open
Journal of Pharmacology and Experimental Therapeutics
Neuropharmacology
Epilepsy & Behavior
Neurology

Among their recent publications are:

"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors," 2021, Neuropharmacology
"Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats," 2021, Epilepsia Open
"Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats," 2023, Journal of Pharmacology and Experimental Therapeutics
"Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats," 2023, Journal of Pharmacology and Experimental Therapeutics
"Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development," 2023, Epilepsy & Behavior

Wasterlain frequently collaborates with several researchers, including:

Jérôme Niquet
Lucille A. Lumley
Marcio de Araujo Furtado
Michael F. Stone
Caroline R. Schultz

Best Publications

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

David E Naylor;Hantao Liu;Claude G Wasterlain

708
Citations
Status epilepticus: pathophysiology and management in adults

James W Y Chen;Claude G Wasterlain

649
Citations
Pathophysiological mechanisms of brain damage from status epilepticus.

Claude G. Wasterlain;Denson G. Fujikawa;Denson G. Fujikawa;LaRoy Penix;LaRoy Penix;Raman Sankar;Raman Sankar

570
Citations
Patterns of Status Epilepticus-Induced Neuronal Injury during Development and Long-Term Consequences

R. Sankar;D. H. Shin;D. H. Shin;Hantao Liu;A. Mazarati

509
Citations
Time dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus

Andrey M Mazarati;Andrey M Mazarati;Roger A Baldwin;Raman Sankar;Claude G Wasterlain;Claude G Wasterlain

297
Citations
Apoptosis in a Neonatal Rat Model of Cerebral Hypoxia-Ischemia

Mark R. Pulera;Lisa M. Adams;Hantao Liu;Donaldson G. Santos

293
Citations
Experimental Models of Epilepsy: A Manual for the Laboratory Worker.

Unknown

266
Citations
Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus

David E. Naylor;Hantao Liu;Jerome Niquet;Jerome Niquet;Claude G. Wasterlain;Claude G. Wasterlain

257
Citations
Modulation of Hippocampal Excitability and Seizures by Galanin

Andrey M. Mazarati;John G. Hohmann;Andrea Bacon;Hantao Liu

248
Citations
Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports

Matthew Walker;Helen Cross;Shelagh Smith;Camilla Young

241
Citations
Vulnerability of Developing Rat Brain to Electroconvulsive Seizures

Claude G. Wasterlain;Fred Plum

230
Citations
Galanin Modulation of Seizures and Seizure Modulation of Hippocampal Galanin in Animal Models of Status Epilepticus

Andrey M. Mazarati;Hantao Liu;Ursel Soomets;Ursel Soomets;Raman Sankar

221
Citations
18FDG positron emission computed tomography in a study of aphasia

E. Jeffrey Metter;E. Jeffrey Metter;Claude G. Wasterlain;Claude G. Wasterlain;David E. Kuhl;Wayne R. Hanson

217
Citations
Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat

H. Hattori;A. M. Morin;P. H. Schwartz;D. G. Fujikawa

200
Citations
N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat

Andrey M. Mazarati;Claude G. Wasterlain

197
Citations
Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy.

I Spigelman;X.-X Yan;A Obenaus;E.Y.-S Lee

196
Citations
Effects of neonatal status epilepticus on rat brain development

Claude G. Wasterlain

192
Citations
Seizures, brain damage and brain development

Claude G. Wasterlain;Claude G. Wasterlain;Yukiyoshi Shirasaka;Yukiyoshi Shirasaka

170
Citations
Recurrent seizures in the developing brain are harmful.

Claude G. Wasterlain

164
Citations
Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neonatal rat

Haruo Hattori;Claude G. Wasterlain;Claude G. Wasterlain

155
Citations
Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat

Raman Sankar;Don H Shin;Claude G Wasterlain

153
Citations
Advances in Epileptology: XVIth Epilepsy International Symposium

Claude G. Wasterlain

14
Citations